SENORESPharmaceuticals
Senores Pharmaceuticals Ltd — Balance Sheet
₹759.60
+0.92%
Senores Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Ordinary Shares Number | 4.61 Cr | 4.61 Cr | 4.61 Cr | 4.61 Cr |
| Share Issued | 4.61 Cr | 4.61 Cr | 4.61 Cr | 4.61 Cr |
| Net Debt | 199.38 Cr | 240.74 Cr | 60.66 Cr | 12.19 Cr |
| Total Debt | 314.75 Cr | 257.64 Cr | 62.59 Cr | 14.76 Cr |
| Tangible Book Value | 565.38 Cr | 50.87 Cr | -0.94 Cr | 27.75 Cr |
| Invested Capital | 1.09K Cr | 452.65 Cr | 106.26 Cr | 50.80 Cr |
| Working Capital | 481.73 Cr | 3.41 Cr | -0.55 Cr | 17.17 Cr |
| Net Tangible Assets | 565.38 Cr | 50.87 Cr | -0.94 Cr | 27.75 Cr |
| Capital Lease Obligations | 9.99 Cr | 9.26 Cr | 1.83 Cr | 0.55 Cr |
| Common Stock Equity | 786.19 Cr | 204.27 Cr | 45.50 Cr | 36.59 Cr |
| Total Capitalization | 948.65 Cr | 337.92 Cr | 75.23 Cr | 48.81 Cr |
| Total Equity Gross Minority Interest | 812.25 Cr | 231.71 Cr | 45.50 Cr | 36.59 Cr |
| Minority Interest | 26.06 Cr | 27.44 Cr | 0.00 | 0.00 |
| Stockholders Equity | 786.19 Cr | 204.27 Cr | 45.50 Cr | 36.59 Cr |
| Other Equity Interest | 740.14 Cr | — | — | — |
| Capital Stock | 46.05 Cr | 30.50 Cr | 9.81 Cr | 8.74 Cr |
| Common Stock | 46.05 Cr | 30.50 Cr | 9.81 Cr | 8.74 Cr |
| Total Liabilities Net Minority Interest | 414.61 Cr | 390.17 Cr | 85.55 Cr | 22.56 Cr |
| Total Non Current Liabilities Net Minority Interest | 173.91 Cr | 142.67 Cr | 33.67 Cr | 12.68 Cr |
| Other Non Current Liabilities | -0.01 Cr | — | — | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 2.10 Cr | 0.00 |
| Long Term Debt And Capital Lease Obligation | 170.66 Cr | 141.43 Cr | 31.32 Cr | 12.62 Cr |
| Long Term Capital Lease Obligation | 8.20 Cr | 7.78 Cr | 1.58 Cr | 0.41 Cr |
| Long Term Debt | 162.46 Cr | 133.66 Cr | 29.73 Cr | 12.22 Cr |
| Long Term Provisions | 3.26 Cr | — | — | — |
| Current Liabilities | 240.70 Cr | 247.50 Cr | 51.88 Cr | 9.88 Cr |
| Other Current Liabilities | 6.03 Cr | — | — | — |
| Current Debt And Capital Lease Obligation | 144.09 Cr | 116.21 Cr | 31.28 Cr | 2.13 Cr |
| Current Capital Lease Obligation | 1.79 Cr | 1.48 Cr | 0.25 Cr | 0.14 Cr |
| Current Debt | 142.30 Cr | 114.73 Cr | 31.03 Cr | 1.99 Cr |
| Current Provisions | 2.06 Cr | 1.02 Cr | 0.04 Cr | 60000.00 |
| Payables | 80.71 Cr | 128.76 Cr | 18.52 Cr | 7.47 Cr |
| Total Tax Payable | 13.49 Cr | 7.11 Cr | 1.58 Cr | 0.13 Cr |
| Accounts Payable | 67.22 Cr | 113.01 Cr | 13.58 Cr | 7.14 Cr |
| Total Assets | 1.23K Cr | 621.88 Cr | 131.05 Cr | 59.15 Cr |
| Total Non Current Assets | 504.43 Cr | 370.97 Cr | 79.72 Cr | 32.10 Cr |
| Other Non Current Assets | 7.38 Cr | — | 10000.00 | 20000.00 |
| Non Current Deferred Taxes Assets | 18.67 Cr | 14.96 Cr | 0.00 | 0.45 Cr |
| Investmentin Financial Assets | 5.19 Cr | 19.48 Cr | 0.40 Cr | 0.14 Cr |
| Available For Sale Securities | 5.19 Cr | 19.48 Cr | 0.40 Cr | 0.14 Cr |
| Goodwill And Other Intangible Assets | 220.81 Cr | 153.40 Cr | 46.44 Cr | 8.84 Cr |
| Other Intangible Assets | 182.60 Cr | 115.19 Cr | 46.44 Cr | 8.84 Cr |
| Goodwill | 38.21 Cr | 38.21 Cr | 0.00 | 0.00 |
| Net PPE | 252.38 Cr | 182.15 Cr | 16.20 Cr | 6.11 Cr |
| Gross PPE | 252.38 Cr | 189.60 Cr | 16.72 Cr | 6.27 Cr |
| Construction In Progress | 44.17 Cr | 20.81 Cr | 8.99 Cr | 0.34 Cr |
| Other Properties | 208.21 Cr | 0.20 Cr | 0.17 Cr | — |
| Current Assets | 722.43 Cr | 250.91 Cr | 51.34 Cr | 27.05 Cr |
| Other Current Assets | 39.45 Cr | — | — | — |
| Inventory | 56.63 Cr | 37.37 Cr | 3.12 Cr | 2.98 Cr |
| Taxes Receivable | 0.00 | — | — | — |
| Accounts Receivable | 123.88 Cr | 112.01 Cr | 22.11 Cr | 19.63 Cr |
| Cash Cash Equivalents And Short Term Investments | 502.47 Cr | 12.86 Cr | 0.10 Cr | 3.21 Cr |
| Other Short Term Investments | 397.09 Cr | 5.21 Cr | — | 1.20 Cr |
| Cash And Cash Equivalents | 105.38 Cr | 7.65 Cr | 0.10 Cr | 2.02 Cr |
| Retained Earnings | — | 41.57 Cr | 10.11 Cr | 1.68 Cr |
| Additional Paid In Capital | — | 134.23 Cr | 25.18 Cr | 23.57 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 1.24 Cr | 0.26 Cr | 0.05 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.36 Cr | 0.05 Cr | 10000.00 |
| Other Payable | — | 8.65 Cr | 3.36 Cr | 0.20 Cr |
| Non Current Prepaid Assets | — | 0.98 Cr | 0.12 Cr | 0.11 Cr |
| Long Term Equity Investment | — | 70000.00 | 16.45 Cr | 15.40 Cr |
| Investments In Other Ventures Under Equity Method | — | 70000.00 | 0.00 | 0.00 |
| Investmentsin Subsidiariesat Cost | — | 0.00 | 16.45 Cr | 15.40 Cr |
| Accumulated Depreciation | — | -7.45 Cr | -0.52 Cr | -0.15 Cr |
| Machinery Furniture Equipment | — | 58.75 Cr | 0.12 Cr | 0.04 Cr |
| Buildings And Improvements | — | 59.91 Cr | 2.13 Cr | 0.57 Cr |
| Land And Improvements | — | 49.93 Cr | 5.30 Cr | 5.30 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 21.01 Cr | 9.14 Cr | 1.22 Cr |
| Finished Goods | — | 5.07 Cr | 2.88 Cr | 2.40 Cr |
| Work In Process | — | 5.20 Cr | 0.00 | 0.00 |
| Raw Materials | — | 27.11 Cr | 0.24 Cr | 0.58 Cr |
| Other Receivables | — | 67.67 Cr | 16.87 Cr | — |
| Allowance For Doubtful Accounts Receivable | — | -0.23 Cr | -0.16 Cr | 0.00 |
| Gross Accounts Receivable | — | 112.23 Cr | 22.27 Cr | 19.63 Cr |
| Cash Financial | — | 7.65 Cr | 0.10 Cr | 2.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Senores Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.